电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant CD40L (Ruplizumab Biosimilar) 抗体

This anti-CD40L (Ruplizumab Biosimilar) antibody is a Human 单克隆 antibody detecting CD40L (Ruplizumab Biosimilar) in FACS, WB 和 Func. Suitable for 人 和 犬.
产品编号 ABIN5564228
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Recombinant CD40L (Ruplizumab Biosimilar) 抗体 (ABIN5564228)

抗原

CD40L (Ruplizumab Biosimilar) (CD40LG (Ruplizumab Biosimilar))

抗体类型

Recombinant Antibody

适用

人, 犬

宿主

  • 4
  • 1
  • 1
  • 1
Human

克隆类型

  • 4
  • 3
单克隆

标记

  • 6
  • 1
This CD40L (Ruplizumab Biosimilar) antibody is un-conjugated

应用范围

  • 6
  • 3
  • 3
  • 2
  • 1
Flow Cytometry (FACS), Western Blotting (WB), Functional Studies (Func)

克隆位点

Hu5c8
  • 特异性

    Recognizes and binds human CD40L with an IC50 of 0.845 μg/mL.

    交叉反应

    犬, 人

    交叉反应 (详细)

    Cross-reacts with canine CD40L.

    纯度

    >95 % (SDS-PAGE)

    内毒素水平

    <0.001EU/μg

    免疫原

    Recombinant human CD40L.

    亚型

    IgG1
  • 说明

    This antibody is a biosimilar called Ruplizumab (Antova, BG9588) and originally developed by Biogen. Ruplizumab is a CD40 ligand blocker designed for the treatment of rheumatic diseases like systemic lupus erythematosus and lupus nephritis, but withdrawn from clinical trials due to side effects.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    Lot specific

    缓冲液

    In PBS.

    储存液

    Without preservative

    储存条件

    4 °C,-20 °C

    储存方法

    Short Term Storage: +4°C
    Long Term Storage: -20°C
    Stable for at least 1 year after receipt when stored at -20°C. Stable for at least 3 months after receipt when stored at +4°C.

    有效期

    12 months
  • 抗原

    CD40L (Ruplizumab Biosimilar) (CD40LG (Ruplizumab Biosimilar))

    别名

    CD40L (Ruplizumab Biosimilar)

    物质类

    Biosimilar

    背景

    CD40 Ligand (CD40L), renamed TNFSF5 but now also known as CD154, TRAP and gp39, is a 34-39 kDa type II transmembrane glycoprotein, that belongs to the TNF superfamily, and a surface receptor expressed on activated T cells which acts as a costimulatory molecule to trigger immune responses. CD40L binds to CD40, which is essential in mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development and germinal center formation. CD40 is constitutively expressed by antigen presenting cells, including dendritic cells, B cells and macrophages. Consistent with its widespread expression on normal cells, CD40 is also expressed on a wide range of tumor cells. CD40L levels are increased in serum and in inflamed tissues of patients with autoimmune diseases.

    UniProt

    P29965
You are here: